Susquehanna International Group
VIVE

Susquehanna International Group’s VIVEVE MED INC VIVE Stock Holding History

Susquehanna International Group’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-16
Closed -$17K – 10147
2018
Q4 		$17K Sell
16
-22
-58% -$52.8K ﹤0.01% 8704
2018
Q3 		$103K Buy
+38
New +$108K ﹤0.01% 8598

Other funds holding VIVE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Susquehanna International Group's VIVE Position: Q4 2021 in Review

Susquehanna International Group sold out of VIVEVE MED INC (VIVE) in Q4 2021, closing a stake of 27,594 shares — an estimated $63K sold.

Susquehanna International Group first reported a position in VIVE in Q3 2018 and held it in 3 quarters. The position peaked at $93K in Q3 2018. 19 funds tracked by Wall St. Rank hold VIVE as of Q4 2021.

  • Susquehanna International Group reported no remaining VIVEVE MED INC position as of Q4 2021 after selling out during the quarter.
  • Susquehanna International Group sold 27,594 VIVEVE MED INC shares in Q4 2021, an estimated $63K.
  • Susquehanna International Group first reported a position in VIVEVE MED INC in Q3 2018 and held it in 3 quarters.
  • Susquehanna International Group's VIVEVE MED INC position peaked at $93K in Q3 2018.
  • 19 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q4 2021.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.